Mixed Cellularity Classical Hodgkin Lymphoma
1 clinical trials · Condition
◉ Watch Mixed Cellularity Classical Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma (NCT03226249) | Northwestern University | 2017-11-09 |
Track Mixed Cellularity Classical Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.